Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Signs and Symptoms » Signs and Symptoms, Respiratory
Description
Respiratory system manifestations of diseases of the respiratory tract or of other organs. MeSH
Hierarchy View
Subtype Terms (19)
Apnea
19 drugs (15 approved, 4 experimental)
Brief, Resolved, Unexplained Event
Cheyne-Stokes Respiration
2 drugs (1 approved, 1 experimental)
Cough
125 drugs (55 approved, 70 experimental)
Dyspnea
42 drugs (29 approved, 13 experimental)
Epistaxis
19 drugs (14 approved, 5 experimental)
Hemoptysis
7 drugs (6 approved, 1 experimental)
Hoarseness
2 drugs (1 approved, 1 experimental)
Hypercapnia
8 drugs (5 approved, 3 experimental)
Hyperoxia
3 drugs (1 approved, 2 experimental)
Hyperventilation
1 approved drug
Hypocapnia
1 experimental drug
Hypoventilation
1 approved drug
Hypoxia
75 drugs (49 approved, 26 experimental)
Respiratory Sounds
25 drugs (17 approved, 8 experimental)
Rhinorrhea
6 drugs (4 approved, 2 experimental)
Sneezing
7 drugs (5 approved, 2 experimental)
Tachypnea
2 approved drugs
Phase 4 Indicated Drugs (5)
Phase 2 Indicated Drugs (1)
Organization Involved with Phase 4 Indications (4)
Organization Involved with Phase 3 Indications (7)
Organization Involved with Phase 2 Indications (1)
Organization Involved with Other Experimental Indications (11)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
